Actively Recruiting
Evaluation of Perceived Outcomes With AGZ: A Randomized, Controlled Consumer Perception Study on Sleep Supplement Effects
Led by Athletic Greens International · Updated on 2026-02-11
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a prospective, randomized, controlled clinical study to evaluate perceived outcomes related to sleep, relaxation, stress, and daytime sleepiness. The study aims to compare the effects of a powdered sleep supplement against participants' usual diet over a 30-day period. Participants will complete questionnaires at specific times to assess their experiences of evening relaxation, sleep quality, and morning vitality. Participants will be randomly assigned to one of two groups: one receiving the powdered sleep supplement and the other maintaining their usual diet without intervention. The treatment period lasts 30 days, during which participants will follow study instructions and limit certain substances like caffeine and alcohol near bedtime. The study does not involve any masking or blinding, and healthy volunteers between 25 and 59 years old are eligible. During the study, participants will complete questionnaires on days 1, 3, 7, 14, and 30 to measure evening relaxation, sleep quality, and morning vitality. Researchers will monitor adherence to the protocol, including restrictions on other supplements, medications, and lifestyle habits that may affect sleep. The total participation time is 30 days, with no additional extension or follow-up periods described.
CONDITIONS
Brief Title
Sleep and Morning Wellbeing Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female.
- Age 25-59 years.
- BMI between 18.5 and 29.9 kg/m².
- Currently experiencing issues with sleep quality, falling asleep, staying asleep, or waking during the night.
- RU-SATED score of 17 or lower.
- Willing and able to follow the study protocol.
- Willing to stop using other supplements, medications, herbal remedies, or over-the-counter sleep aids during the study.
- Agree to limit alcohol intake within about 4 hours of bedtime during participation.
- Agree to limit caffeine intake to 400 mg/day and avoid caffeine after 2:00 PM during the study.
- Generally healthy without uncontrolled chronic diseases.
- Resides in the United States.
- Willing to adhere to all study assessments and restrictions.
You will not qualify if you...
- Diagnosed chronic sleep conditions such as insomnia, narcolepsy, REM Behavior Disorder, moderate to severe restless leg syndrome, or sleep apnea.
- Current use of sleep-tracking technology that could influence sleep behavior or perception.
- Women currently undergoing perimenopause or experiencing vasomotor symptoms like night sweats.
- Use of hormone therapy within the last 3 months.
- Diagnosed psychiatric disorders with active symptoms including major depressive disorder, bipolar disorder, generalized anxiety disorder, and PTSD.
- Diagnosed neurodegenerative or chronic pain disorders such as Parkinson's disease, Alzheimer's disease, or uncontrolled fibromyalgia.
- Regular prescribed stimulant use or current use of CNS-activating antidepressants.
- Recent use of cannabis or THC-containing products within the past 30 days.
- Employment in jobs that disrupt nighttime sleep such as night or rotating shifts.
- Current use of prescription sleep aids or sedative products within 4 weeks prior to enrollment.
- Allergy or sensitivity to any study product ingredients.
- Pregnant, breastfeeding, or trying to conceive during the study period.
- History of substance abuse.
- Heavy alcohol use (8 or more drinks/week for women or 15 or more drinks/week for men).
- Participation in another research study now or within the next 7 weeks.
- Any condition or behavior that might interfere with study participation or data integrity as judged by the investigator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual) for eligibility assessment
Duration - 30 days
Participants take the sleep supplement or maintain their usual diet to evaluate effects on evening relaxation, sleep quality, and morning vitality.
5 visits on Days 1, 3, 7, 14, and 30 (may be remote or in-person)
Trial Site Locations
Total: 1 location
1
Alethios (Virtual Study Platform)
San Francisco, California, United States, 94117
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here